Patent · US Active

Testing environment cyber vaccine

US10419479B2 · kind B2 · utility

2Cited by
4References
20Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 23, 2017
Grant dateSep 17, 2019
Priority date
Expiry dateMar 23, 2037

Classification

  • Technology area (CPC H)Electricity
  • CPC primaryH04L63/145
  • WIPO fieldDigital communication
  • WIPO sectorElectrical engineering

Abstract

Provided are systems, methods, and computer program products for a cyber-vaccination technique. In various implementations, the technique includes determine characteristics of a testing environment. A testing environment can be used to analyze malware programs. The technique can further include configuring a production network device with the characteristics, so that the production network device resembles the testing environment. The production network device is used for network operations, which excludes analyzing malware programs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.